A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib ; volume:12 ; number:1 ; day:29 ; month:11 ; year:2022 ; pages:1-10 ; date:12.2022
Scientific reports ; 12, Heft 1 (29.11.2022), 1-10, 12.2022
- Urheber
-
Guo, Menglin
Shu, Yamin
Chen, Guosong
Li, Juan
Li, Feie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-23726-4
- URN
-
urn:nbn:de:101:1-2023020921471768079717
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guo, Menglin
- Shu, Yamin
- Chen, Guosong
- Li, Juan
- Li, Feie
- SpringerLink (Online service)
Ähnliche Objekte (12)
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
What Makes Nurses Intend To Leave Their Profession? International Comparison
Direct assimilation of Chinese FY-3C Microwave Temperature Sounder-2 radiances in the global GRAPES system
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
What Makes Nurses Intend To Leave Their Profession? International Comparison
Direct assimilation of Chinese FY-3C Microwave Temperature Sounder-2 radiances in the global GRAPES system
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617
Safety assessment of Tafamidis: a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events
A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database
What Makes Nurses Intend To Leave Their Profession? International Comparison
Direct assimilation of Chinese FY-3C Microwave Temperature Sounder-2 radiances in the global GRAPES system
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Safety of talimogene laherparepvec: a real‐world retrospective pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS)
A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System